Vitality Watch

Dossier pubmed review 24-jun-2026
Narrative review or expert overview without new data

Advances in skin aging: integrating epigenetic, cellular, and immune mechanisms for targeted therapy.

Key claim: Skin aging is driven by interconnected epigenetic drift, cellular senescence with mitochondrial remodeling, and an immunosenescence–inflammaging axis, and may be addressed by mechanism-targeted senotherapeutics, epigenetic/mitochondrial modulators, biologics, and regenerative therapies.

Abstract

As the largest and most externally exposed organ, the skin is particularly vulnerable to aging, rendering skin aging a widespread clinical and aesthetic concern. Driven by both intrinsic and extrinsic factors, skin aging is characterized by progressive functional decline and structural remodeling that compromise barrier integrity, disrupt dermal homeostasis, and ultimately diminish quality of life. At the upstream regulatory level, skin aging-associated epigenetic modifications drive epigenetic drift that compromises transcriptional fidelity and primes cells toward senescence. At the cellular level, regulatory mechanisms converge on cellular senescence and profound mitochondrial remodeling. At the microenvironmental level, the failure of senescent cell clearance (immunosenescence) and the emergence of a chronic pro-inflammatory milieu (inflammaging) create a self-reinforcing immune-inflammatory axis. This axis exacerbates cytokine production, extracellular matrix remodeling, and progressive tissue degeneration. We further highlight emerging mechanism-targeted interventions, including epigenetic and mitochondrial modulators, senotherapeutics, biologics, immunotherapies, regenerative and device-based therapies. A deeper understanding of these interconnected molecular mechanisms and targeted therapies may offer a roadmap for future therapeutic innovation and translational research in skin aging.

Why this matters

Skin aging is driven by interconnected epigenetic drift, cellular senescence with mitochondrial remodeling, and an immunosenescence–inflammaging axis, and may be addressed by mechanism-targeted senotherapeutics, epigenetic/mitochondrial modulators, biologics, and regenerative therapies.

Source

Link

Briefing card

Advances in skin aging: integrating epigenetic, cellular, and immune mechanisms for targeted therapy.
Stage: review · pubmed · 24-jun-2026

Skin aging is driven by interconnected epigenetic drift, cellular senescence with mitochondrial remodeling, and an immunosenescence–inflammaging axis, and may be addressed by mechanism-targeted senotherapeutics, epigenetic/mitochondrial modulators, biologics, and regenerative therapies.

Cross-references (0)

None recorded — doctrine links and citations appear here as scans and citation sweeps find them.

External: doi:10.1186/s12979-026-00578-4

build build 880 · 2bcef25 · 2026-11-18